CRASH2 logo
LSHTM logo
Worldwide research and postgraduate education in global health
Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage
A large randomised placebo controlled trial among trauma patients with, or at risk of, significant haemorrhage, of the effects of antifibrinolytic treatment on death and transfusion requirement
ISRCTN86750102

FINAL RESULTS PUBLISHED ON LANCET ONLINE ON 15 JUNE 2010

pdf-version

Abstract in Spanish - Hindi - Chinese - Japanese

Press release

What did the collaborators think? See their comments HERE

20,000 PATIENTS RANDOMISED

Congratulations to all our 274 collaborating hospitals in 40 countries for completing the randomisation of 20,000 patients!

Last updated 16 June 2010